Ozempic and the uncomfortable truth

Weight Loss Drugs: A New Perspective on Metabolic Activity

The world of weight loss medications is being reevaluated following a study led by Professor Donal O'Shea of St. Vincent's University Hospital (SVUH) and the UCD School of Medicine. The research focused on the medication Ozempic, a drug that has been under public scrutiny for some time. The study's findings, published in the Journal of the Obesity Society, challenge the prevailing belief that weight loss medications like Ozempic, Wegovy, or Monjaro primarily work by promoting satiety and reducing food intake. Aug 23, 2024
Second Neuralink chip recipient progressing well: Elon Musk

Neuralink's Second Brain Chip Recipient Shows Promising Progress

Elon Musk, the founder of Tesla and SpaceX, has announced that the second recipient of the Neuralink brain chip is showing promising progress. Musk, who is also the founder of Neuralink, expressed optimism about the future of the brain-computer interface company, predicting widespread adoption of its brain chip within the next decade. Aug 23, 2024